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Abstract
The prevalence of overweight and obesity among children and adolescents has increased
considerably over the last few decades. As a result, increasing numbers of American
children are developing multiple risk factors for cardiovascular disease, type II diabetes,
hyperinsulinemia, hypertension, dyslipidemia and hepatic steatosis.
This thesis examines the use of Monte Carlo computer simulation for understanding risk
factors associated with childhood overweight. A computer model is presented for
predicting cardiovascular risk factors among overweight children and adolescents based
on BMI levels.
The computer model utilizes probabilities from the 1999 Bogalusa Heart Study authored
by David S. Freedman, William H. Dietz, Sathanur R. Srinivasan and Gerald S.
Berenson. The thesis examines strengths, weaknesses and opportunities associated with
the developed model. Utilizing this approach, organizations can insert their own
probabilities and customized algorithms for predicting future events.
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I. Introduction
The prevalence of overweight and obesity among children and adolescents has
increased considerably over the last few decades. According the American Medical
Association, the prevalence of overweight tripled in children and adolescents aged 6 – 19
years between 1980 and 2002 (Ogden, Carroll, Curtin, et al. 2006, p1549). As this trend
continues, increasing numbers of American children are developing multiple risk factors
for cardiovascular disease, type II diabetes, hyperinsulinemia, hypertension, dyslipidemia
and hepatic steatosis. For the majority, health-related consequences begin in childhood
and continue well into adulthood.
In response to this problem, organizations across America are banding together in
the fight against childhood overweight. These partnerships focus on a variety of issues
ranging from behavior to nutrition to physical activity. However, limited resources
require organizations to carefully select only the most effective and efficient
interventions. These decisions require thorough evaluation of national trends, scientific
evidence and long-term strategies.
Organizations seeking to identify successful strategies require access to a wide
variety of effective decision-making tools. The purpose of this thesis is to examine the
use of Monte Carlo computer simulation as a tool for assisting organizations in
identifying effective strategies for fighting childhood overweight. Utilizing this
approach, organizations can insert their own probabilities and customized algorithms for
predicting future events.
II. Background
The problem of overweight and obesity in the U.S. is not just a personal issue but
rather a problem that impacts the quality of life, economic performance and
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physical/mental status of whole populations. For example, consider the implications of
overweight on the U.S. economy. Significant attention is given to the rising cost of
health care. Health expenditures as a percentage of GDP in the United States have
increased from less then three percent in the 1970’s to approximately 16 percent in 2004
(see Figure II-1). The United States spends more on health care, in terms of per capita
health spending, than any other nation members of the Organization for Economic
Cooperation and Development (OECD). Considerations for many factors including
quality, capacity and innovation are required before making judgments regarding the
positive and/or negative implications of these spending trends. However, it is not
disputed that health care expenditures are significant and growing.
Figure II-1 Total national health expenditures and as a percentage of GDP

Source: Custer, William S. (January, 2006). HA8250: Health Economics and Financing. Class Lecture
1 Georgia State University
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Researchers project that health spending will increase to $3.4 trillion, or almost
20% of the GDP by 2013 (Hefler, Smith, Keehan, et al. 2004, p82). To undertake any
serious attempt at controlling cost, policymakers must seek to more fully integrate public
health into the U.S. health care system. It is usually cheaper to prevent illness, than to
treat illness.
Chronic disease
In an effort to effectively control health care cost, the U.S. must focus on the
problem of chronic disease. Chronic conditions are defined as illnesses or impairments
that last a year or longer. According to the CDC’s National Center for Chronic Disease
Prevention and Health Promotion, more than 90 million Americans live with chronic
illnesses and chronic diseases account for more than 75% of the nation’s $1.4 trillion of
medical care costs (National Center for Chronic Disease Prevention and Health
Promotion, 2005, p3).
Chronic diseases, such as cardiovascular disease (primarily heart disease and
stroke), cancer, and diabetes, are among the most prevalent, costly, and preventable of all
health problems (National Center for Chronic Disease Prevention and Health Promotion,
2005, p2).
Overweight – A major contributor to chronic disease
Research shows that “the risk of developing diabetes, gallstones, hypertension,
heart disease and stroke increases with severity of overweight among both women and
men” (Field, Coakley, Must, et al. 2001, p1581).
According to Calle and Walker-Thurmond, “In both men and women, body-mass
index was significantly associated with higher rates of death due to cancer of the
esophagus, colon and rectum, liver, gallbladder, pancreas, and kidney; the same was true
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for death due to non-Hodgkin’s lymphoma and multiple myeloma. Significant trends of
increasing risk with higher body-mass-index values were observed for death from cancers
of the stomach and prostate in men and for death from cancers of the breast, uterus,
cervix, and ovary in women” (Calle, Rodriguez, Walker-Thurmond, et al. 2003, p1625).
As the number of overweight children and adolescents in the U.S. increases so
will the number of overweight adults. Figure II-2 shows the probability of overweight at
age 35 predicted from childhood BMI at the 95th percentile. According to Guo and
Chumlea “Body mass index values at or above the 75 percentile are associated with
increased morbidity and mortality in adulthood, and there are significant correlations
between BMI values in childhood and in adulthood (Guo and Chumlea 1999, p145)
Figure II-2 Probability of overweight at age 35 predicted from childhood BMI at the 95th percentile

Source: Guo, S.S., Chumlea, W.C. (1999) Tracking of body mass index in children in relation to
overweight in adulthood. The American Journal of Clinical Nutrition, 145, 145-147.

Health related consequences of child and adolescent overweight
The problem of overweight in children and adolescent is associated with several
health-related consequences. The negative impact of these consequences may be
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experienced in childhood and/or be experienced later on in adulthood. Overweight
children and adolescents are at an increased risk for:
Cardiovascular Disease – Risk factors include abnormal cholesterol levels, hypertention,
elevated triglycerides and glucose intolerance. Studies have shown “an evolving
epidemic of cardiovascular risk in youth, as evidence by an increase in the prevalence of
overweight’ (Sorof, Lai, Turner, et al. 2004, p475).
Psychosocial Risks and Discrimination – Overweight children are often targets of early
social discrimination. Social stigmatization and negative stereotyping can cause
psychological stress and low self-esteem which, in turn, can hinder academic and social
functioning that persists well into adulthood (CDC, 2007). Other social and emotional
health consequences include social marginalization, teasing/bullying, depression and
negative body image (Institute of Medicine, 2004, p2).
Glucose Intolerance – a pre-diabetic state, that is associated with insulin resistance and
increased risk of cardiovascular pathology (Institute of Medicine, 2004, p2).
Diabetes Mellitus Type II / Insulin Resistance – What was once considered primarily an
adult disease, type 2 diabetes has increased dramatically in children and adolescents.
Overweight and obesity are closely associated with type 2 diabetes (Pi-Sunyer, 2002,
p23S).
Hyperinsulinemia – A condition where excess levels of circulating insulin are in the
blood. It is not diabetes, but it is often associated with metabolic syndrome and type 2
Diabetes (Pi-Sunyer, 2002, p22S).
Dyslipidemia – Overweight is associated with disruptions in the amount of lipids in the
blood (Institute of Medicine, 2004, p2).
Hepatic Steatosis (a.k.a. fatty liver) –A reversible condition where large vacuoles of lipid
accumulate in hepatocytes (the cells of the liver). Hepatic Steatosis is a health condition
associated with increased weight (CDC, 2007, p1).
Other associated health conditions include orthopedic problems (Institute of
Medicine, 2004), sleep apnea (CDC, 2007), gallstones (Institute of Medicine, 2004),
asthma (Gennuso, Epstein, Paluch, et al. 1998), reproductive complications (Cnattingius,
Bergstrom, Lipworth, et al. 1998) and menstrual abnormalities (Institute of Medicine,
2004).
Given the correlation between overweight children and overweight adults, health
conditions associated with childhood overweight expand to include cancer and arthritis.
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Fourteen percent of cancer deaths among men and 20% of cancer deaths among women
may be due to overweight and obesity (Calle, Rodriguez, Walker-Thurmond, et al. 2003).
Arthritis is the leading cause of disability in the United States. According to the U.S.
Department of Health and Human Services (2007), the risk of developing arthritis
increases by 9-13% for every two-pound increase in weight.
Interventions for overweight (and its corresponding chronic diseases) will require
multifaceted approaches that seek to reverse years of cultural, behavioral and social
norms. Interventions must address root cause, begin early in life to establish lifelong
pattern of behavior and utilize effective methodologies for tracking progress.
Tracking overweight: National Health and Nutrition Examination Surveys
(NHANES)
Two primary tools for tracking overweight in children and adolescents include the
National Health and Nutrition Examination Survey (NHANES) and the Centers for
Disease Control and Prevention growth charts.
In 1956, Congress passed the National Health Survey Act providing
legislative authority for a recurring survey to provide statistical data on the amount,
distribution, and effects of illness and disability in the United States. Three sources
of data collection fulfilled this purpose.
•
•
•

Direct interviews with survey participants
Clinical tests, measurements and physical examinations
Information retrieved from hospitals, clinics and doctors offices

In compliance with the National Health Survey Act, three initial surveys were
performed.
1. 1960-62—National Health Examination Survey I (NHES I) – Focused on
selected chronic disease of adults aged 18-79;
2. 1963-65—National Health Examination Survey II (NHES II) - Focused on the
growth and development of children aged 6-11; and
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3. 1966-70—National Health Examination Survey III (NHES III) - Focused on
the growth and development of children aged 12-17
In 1970, the Secretary of the Department of Health directed that additional
emphasis be placed on nutrition. As a result, the National Nutrition Surveillance System
was implemented. The purpose of the system was to measure and track the nutritional
status of the U.S. population.
Data from both systems were combined in the 1970’s to form the National Health
and Nutrition Examination Surveys (NHANES). Four surveys were conducted between
1970 and 1994.
•
•
•
•

1971-75—National Health and Nutrition Examination Survey I (NHANES I)
1976-80—National Health and Nutrition Examination Survey II (NHANES
II)
1982-84—Hispanic Health and Nutrition Examination Survey (NHANES)
1988-94—National Health and Nutrition Examination Survey III (NHANES
III)

Since 1999, the NHANES survey has been performed annually. Each year,
approximately 7,000 randomly selected residents across the United States have the
opportunity to participate (NCHS, 2007). Today, the survey is a valuable tool in
providing objective assessment data of health status and overweight for individuals living
in the United States.
Tracking overweight: Centers for Disease Control growth charts
In 1977, the National Center for Health Statistics (NCHS) developed a series of
growth charts for the purpose of assessing the development of children and youth. The
growth charts were developed utilizing data from the Fels Research Institute. Data
consolidated empirical data of youth between the years 1929 and 1975. In 1978, the
Centers of Disease Control and Prevention created a normalized version of the NCHS
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percentiles to serve as an easy reference for pediatricians (Dibley, Goldsby, Staehling, et
al. 1987, p736).
The 1977 NCHS growth charts gained national and international recognition as a
standard for assessing the health status of infants and youth. The charts served as a
cornerstone in research and are referenced in numerous studies evaluating prevalence,
trends, population comparisons and interventions. At the international level, the World
Health Organization (WHO) adopted the 1977 charts as standard reference (World Health
Organization, 1978).
As the charts gained in popularity, they also underwent scrutiny. The primary
issues centered on the validity of the Fels data. Inconsistencies include mismatches
between NCHS percentiles and 1978 versions of normalized data, methodologies used for
adjusting adolescent data versus younger children, over-representation of formula fed
infants and non-representative datasets. At the time, these data were the best available
and limitations were clearly stated in the initial release.
To address these issues the Centers for Disease Control and Prevention released a
series of updated growth charts in May of 2000 (see Appendix A). Today, these same
growth charts are the recommended standard for assessing children in the United States.
The measurement data for creating the revised growth charts were obtained from a series
of sources including:
•
•
•
•
•
•
•

National Health Examination Survey (NHES), Cycles II and III
National Health and Nutrition Examination Survey (NHANES) I, II, and III
U.S. Vital Statistics
Wisconsin Vital Statistics
Missouri Vital Statistics
Fels Longitudinal Study
Pediatric Nutrition Surveillance System
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Survey-specific sample weights were applied to the national survey sample data
to assure representation of the U.S. population according to age, gender, and racial/ethnic
composition at the time the surveys were conducted (CDC, 2007).
Defining overweight in children and adolescents
Several methodologies exist for measuring overweight in children and
adolescents. Methodologies include body mass index, skin fold thickness measurements
utilizing calipers, underwater weighing, bioelectrical impedance, dual-energy x-ray
absorptiometry (DXA) and computerized tomography. However, tracking overweight at
the national level requires adoption and agreement towards a national standard. In
identifying this standard, issues of quality, ease of use (i.e., required training and
equipment) and cost come into consideration. Based on these factors, the CDC
recommends use of body mass index (BMI) for population studies (CDC, 2006).
Quetelet index
The quetelet index (or body mass index) was invented between 1830 and 1850 by
social scientist Adolphe Quetelet. The index is a statistical measure of the weight of a
person scaled according to height. As the measurement gained popularity during the
1980’s, the term was more commonly referred to as “body mass index”. Both terms are
used interchangeably throughout this thesis to prevent confusion between referenced
studies and data sources.
BMI is one of the best measurements for measuring overweight and obesity in
populations. Only height and weight are required, making BMI screening easy and
inexpensive. BMI is calculated the same way for both adults and children. According to
the CDC (2006), calculations for BMI are as follows:
Equation 1 BMI in kilograms and meters
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Kilograms and meters (or centimeters) = weight (kg) / [height (m)] 2
Equation 2 BMI in pounds and inches

Pounds and inches = weight (lb) / [height (in)] 2 x 703
Although BMI is the recommended standard for population studies, it is not
without its limitations. According to the CDC (2006), BMI correlation to body fatness
“varies by sex, race, and age”. Examples of variance related to BMI include:
•
•
•

At the same BMI, women tend to have more body fat than men do.
At the same BMI, older people, on average, tend to have more body fat than
younger adults do.
Highly trained athletes may have a high BMI because of increased
muscularity rather than increased body fatness.

Interpretations for BMI vary substantially between adult and children.
According to the CDC (2006), weight status for adults is classified as follows:
Table 1 Adult BMI weight status

BMI

Weight Status

Below 18.5

Underweight

18.5 – 24.9

Normal

25.0 – 29.9

Overweight

30.0 and Above

Obese

Source: Centers for Disease Control and Prevention (August 26, 2006). About BMI for Children and
Teens. Retrieved March 10, 2007 from
http://www.cdc.gov/nccdphp/dnpa/bmi/childrens_BMI/about_childrens_BMI.htm

The criteria for establishing weight status in children is slightly more complex.
This is due to significant differences in amount of body fat between boys and girls as well
as for specific age groups. According to the CDC (2006), child and adolescent weight
status is classified as follows:
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Table 2 Child and adolescent weight status

Weight Status
Category
Underweight

Percentile Range
Less than the 5th percentile

Normal

5th percentile to less than the 85th percentile

Overweight

85th to less than the 95th percentile

Obese

Equal to or greater than the 95th percentile

Source: Centers for Disease Control and Prevention (August 26, 2006). About BMI for Children and
Teens. Retrieved March 10, 2007 from
http://www.cdc.gov/nccdphp/dnpa/bmi/childrens_BMI/about_childrens_BMI.htm

Percentile range is defined using the May 2000 growth charts (see Appendix A)
based on a combination of data sources.
Trends in tracking overweight among U.S. children and adolescents
Utilizing the percentile ranges defined in Table 2, the prevalence of overweight
and obesity among U.S. children and adolescents has increased considerably over the last
few decades.
The Institute of Medicine (2004) found that:
“Over the past three decades, the childhood obesity rate has more than
doubled for preschool children aged 2-5 years and adolescents aged 12-19 years, and
it has more than tripled for children aged 6-11 years. At present, approximately nine
million children over 6 years of age are considered obese.” (IOM, 2004, p1)
For detailed prevalence data for children and adolescents who are “at risk of
overweight” and/or “overweight” by sex, age, and racial/ethnic group (see Appendix B &
C).
III. Literature review
The tools of modeling, analysis and simulation are widely used to assess systems
that evolve dynamically and/or have behaviors that are uncertain. Nelson (1995) found
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computerized simulation modeling to be a valuable asset in the following industries and
applications.
Manufacturing – capacity planning, inventory control and evaluation of process
quality
Health-care – hospital staffing and medical decision making
Computer applications – designing hardware configurations and operating-system
protocols
Communication - evaluating network reliability
Economic – portfolio management and forecasting
Business – consumer behavior, product distribution and logistics
Biological – population genetics and epidemiology
The purpose of this thesis is to achieve the following:
Research Objective: This thesis examines the use of Monte Carlo computer
simulation for understanding cardiovascular risk factors associated with childhood
overweight. A computer model is presented for predicting cardiovascular risk
factors among overweight children and adolescents based on BMI percentiles.
The primary benefits of computer modeling include:
Explaining relationships / sensitivity - For example, how do increases in childhood
overweight affect increases in risk factors for elevated triglycerides?
Predicting future events – As an example, if current trends in childhood BMI continue,
what is the expected number of children at risk due to high blood pressure in five years?
Examining “what if” scenarios - In other words, if one variable is modified – what
changes are expected in other variables within the system? For example, if the rate in
number of children who are “overweight” is reduced by half – What is the expected
number of children with elevated total cholesterol?
Monte Carlo modeling
A Monte Carlo simulation is a statistical method involving computer simulation
in which data is generated randomly, enabling assessment of the probabilities of certain
known outcomes. For this study, a random number generator is used to replicate both
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weight status and the occurrence of specific cardiovascular risk factors in children and
adolescents.
Monte Carlo simulation is utilized in several studies for predicting future events
and outcomes in the field of public health. For example, Bray (2002) utilized Markov
Chain Monte Carlo (MCMC) simulation to address a 5-year delay in the publishing of
cancer incidence and mortality rates. Bray noted that current health models are rarely
utilized because of oversimplistic methodologies and/or models that are dependent on
questionable parametric assumptions. Bray proposes a new model based on MCMC
simulation and utilization of Bayesian statistics.
Stuart and colleagues (2003) utilized Monte Carlo experiments to simulate data
loss in testing the robustness of proportion-based quality indicators for asthma. Through
the use of Monte Carlo modeling, asthma quality indicators measures were determined
highly robust to systematic and random data loss.
Chen, Yen and Tung (2001) modeled the disease natural history of Type 2
diabetes mellitus using Monte Carlo Markov processes. The goal of the study was to
determine the cost effectiveness of mass screening in Taiwan. Two separate screening
regimes were compared with a control group. Direct costs and utilities were incorporated
to calculate the incremental costs per life-years gained and per quality-adjusted life-years
for biennial and five-yearly screening regimes. Through the use of Monte Carlo
modeling, the study showed 5-year interval mass-screening for Type 2 diabetes mellitus
to be cost-effective in Taiwan.
Overview of the Bogalusa Heart Study
The computer model utilizes probabilities from the 1999 Bogalusa Heart Study
published by Freedman, Dietz, Srinivasan and Berenson (The relation of overweight to
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cardiovascular risk factors among children and adolescents: The Bogalusa Heart Study.
Pediatrics, 103, 1175–1182). The objective of the Bogalusa Heart Study was to utilize
quetelet index cut points to examine the relation of overweight to adverse risk factors
levels. Table 3 shows the relationships between Quetelet index and adverse
cardiovascular risk factors by age group.
Table 3 Relation of quetelet index to adverse risk factors, by age group
Quetelet Index Percentiles
Ages 5-10 years
Sample Size

<25

25-49

50-74

75-84

85-94

95-97

>97
256

904

817

798

340

384

100

Total Cholesterol > 200 mg/dL

9

10

10

13

18

17

23

Triglycerides > 130 mg/dL

2

3

3

6

10

10

21

Low-Density Lipoprotein Cholesterol > 130 mg/dL

8

8

9

10

18

12

23

High-Density Lipoprotein Cholesterol < 35 mg/dL

5

5

6

4

8

7

18

Fasting Insulin > 95th Percentile

2%

2%

3%

3%

4%

10%

27%

Systolic Blood Pressure > 95th Percentile

2%

2%

4%

6%

7%

12%

22%

Diastolic Blood Pressure > 95th Percentile

2%

2%

4%

9%

7%

9%

14%

Ages 5-10 years

<25

25-49

50-74

75-84

85-94

95-97

>97

Sample Size

1189

1122

1249

611

763

210

424

Total Cholesterol > 200 mg/dL

6

6

7

9

15

12

19

Triglycerides > 130 mg/dL

3

4

5

7

12

18

32

Low-Density Lipoprotein Cholesterol > 130 mg/dL

4

4

6

9

13

12

21

High-Density Lipoprotein Cholesterol < 35 mg/dL

6

9

10

12

14

16

21

Fasting Insulin > 95th Percentile

1%

1%

3%

2%

5%

10%

25%

Systolic Blood Pressure > 95th Percentile

2%

4%

6%

4%

7%

5%

11%

Diastolic Blood Pressure > 95th Percentile

4%

5%

5%

5%

4%

4%

9%

Source: Freedman. D.S., Dietz W.H., Srinivasan. S.R., Berenson. G.S., (1999) The relation of
overweight to cardiovascular risk factors among children and adolescents: The Bogalusa Heart Study.
Pediatrics, 103, 1175–1182.

The Bogalusa (Louisiana) Heart Study included seven cross-sectional
examinations, each with a participation rate of >80% between 1973 and 1994. The study
population was 43,000 (1/3 black, 2/3 white) schoolchildren between the ages of 5 and 17
years. Analysis was restricted to individuals who properly fasted and who had recorded
values for weight, height, total cholesterol and systolic blood pressure. The resulting
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sample included 9,167 schoolchildren between the ages of 5 and 17 years (Freedman,
Dietz, Srinivasan, et al. 1999, p1175).
The Bogalusa study provides valuable insight into cardiovascular risk factors
among children and adolescents. Additionally, the study provides the opportunity for
building a simulation that otherwise would not be possible. However, the study itself
provides only static information - a snapshot in time. It provides great insight into the
prevalence and even incidence of cardiovascular risk factors among children and
adolescents but does not provide any prediction in how risk factors change in relation to
time and/or weight status.
Simulation, on the other hand, is dynamic. Each iteration of a simulation yields
different results. Much like real life, conditions change from day to day. For example,
suppose one’s weight is measured once per week. In the first week, one weighed 175.12
lbs. In the second week, the probability that one would again weigh 175.12 lbs is highly
improbable. One’s weight today is much more likely to fall somewhere above or below
175.12 lbs.
Weight fluctuation may be due to a variety of variables. Some are attributed to
what is called “natural variance”: e.g., at the time of weight measurement an individual
had not eaten breakfast, had lost water from a morning jog, etc. Some changes in weight
are considered “significant”: e.g., eating or exercised habits had changed, the individual
had caught a virus, or became pregnant. Simulation seeks to explain both natural and
significant variance through probability theory.
Additionally, simulation becomes helpful when stringing together multiple
probability distributions. When the number of variables is small, then the calculations
are easily performed. For example, consider the normal probability distribution in Figure
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III-1. The y-axis represents the probability that a randomly selected individual’s average
daily duration of moderate exercise equals the corresponding duration in minutes (xaxis). The ability to compare probabilities for increased vs. decreased exercise is
relatively easy.
Figure III-1 Example probability distribution

Now consider a slightly more complex model in Figure III-2. Assume, again that
distribution A is a probability distribution for average level of exercise. If the
individual’s daily exercise level is significant enough to fall within the dark purple
region, then the probability of getting a particular disease outcome is determined by
distribution B. Otherwise, the probability of getting the particular disease is determined
by distribution C. The final “Predicted Prevalence” is calculated using a combination of
outputs from distributions B and C.
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Figure III-2 Example of a chain of probability distributions

Figure 3-2 provides a good example of the complexity that derives from
syndemics. “Syndemics” is a term invented to describe a set of linked health problems
and is defined as two or more afflictions, interacting synergistically, contributing to
excess burden of a disease in a population (CDC, January 2005). For a more in-depth
explanation on modeling, see Computer Simulation Theoretical Example in Appendix D.
Through simulation, researchers can tweak probabilities to better understand the
impact of certain system events. Simulation may help to answer questions such as:
How do reductions in BMI impact cholesterol levels?
What if interventions target the reduction of BMI for a particular sex and/or
ethnicity group?
What if current trends in BMI continue for 5 years?
What if the trends in BMI stay the same but the risk of hypertension increases?
Simulation has proven helpful in addressing these and many more question of this type.
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Simulation and Probability Theory
Two important laws are critical to the performance of a Monte Carlo simulation.
They are the Law of Large Numbers and Bayes’ Law. The Law of Large Numbers is a
fundamental concept in probability. According to the law:
If an event of probability p is observed repeatedly during independent
repetitions, the ratio of the observed frequency of that event to the total number of
repetitions converges towards p as the number of repetitions becomes arbitrarily
large.
In other words, as an experiment is repeated over and over, the observed probability
approaches the actual probability distribution.
The second law critical to simulation is Bayes Law. Before delving into this law,
it is important to understand the two primary schools of thought for assigning
probabilities to various applications: Frequentist and Bayesian interpretations.
Frequentists assign probabilities to random events based on subsets of a
population as proportions of the whole (Durrett, 1994). For example, in the Bogalusa
Heart Study 432 children ages 5 to 10 years of age are at risk for total cholesterol levels
greater than 200 milligrams/deciliter (md/dL). The total sample size of children ages 5 to
10 screened for total cholesterol is 5,568. Based on these findings the proportion of
children ages 5 to 10 with total cholesterol levels greater than 200 md/dL is 12%. In
other words, using a frequentest view, the probability of a child ages 5 to 10 having a
total cholesterol level greater than 200 md/dL is 0.12.
Bayesian interpretations (or Bayes' Law) is valid for both interpretations of
probability. Bayes' Law relates a condition on the probability distribution (Durrett,
1994). In other words, probabilities are updated in light of new evidence. Using the
example above, a randomly selected 5 to 10 year old has a 0.12 probability of having a
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total cholesterol level exceeding 200 md/dL. If the 5 to 10 year old child, selected at
random, is known to be overweight (i.e., the child has a quetelet index greater than 95%).
This additional information may be used to update the original probability. In light of the
additional information regarding the child's weight status, the child now has 0.17
probability of having a total cholesterol level exceeding 200 md/dL.
The simulation model in this study utilizes quetelet index as a conditional
attribute for each randomly generated event. Probabilities for predicting adverse
cardiovascular risk factors are calculated utilizing the principles of Bayes Law.
IV. Model Development
Utilizing a similar methodology as was described earlier, the cardiovascular risk
factor model simulates trails based on single individuals. Each individual is first assigned
a weight status using a quetelet index. Second, the individual is assessed against a series
of probabilities (thresholds) to determine their susceptibility to various cardiovascular
risk factors. Each probability is determined given the individuals assigned weight status
(i.e., quetelet index).
The term “event” in probability refers to an unknown future result, while the term
“system event” refers to a change in the status of a system (Nelson, 1995, p25). A system
event is synonymous with implementation of an intervention. For example, a single
event may represent a 5 to 10 year old who is assigned a quetelet index in the 88th
percentile. By definition, this individual is considered “at risk of overweight”. The same
child is then assessed for total cholesterol. If this child’s total cholesterol level is greater
than 200 mg/dL, they are considered at risk for cardiovascular disease based on total
cholesterol. A 5-10 year old child with a quetelet index equal to the 85th percentile has a
probability of 0.157 for exceeding the 200 mg/dL threshold. Generating a random
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number between zero and one using a uniform distribution provides the random number
0.235. Because 0.235 is greater than 0.157, this individual in not considered “at risk” for
total cholesterol even though the child is “at risk of overweight”. The same is repeated
for multiple risk factors and for multiple trials until the Law of Large Numbers is
achieved.
Two separate models are assessed. The first will model cardiovascular risk
factors among children ages 5 to 10 years. The second will model cardiovascular risk
factors among adolescents ages 11 to 17 years. These age groups are consistent with the
age groups established in the Bogalusa Heart Study. Age group categories allow for
more accurate predictions of individual quetelet index, risk factor susceptibility as well as
changes in height and weight metrics due to puberty.
@RISK Version 4.5.3
The simulation utilizes @RISK version 4.5.3 (student version) released February
of 2003. The tool is a proprietary product owned by the Palisade Decision Tools
Corporation. @RISK 4.5 is a Monte Carlo simulation add-in for Microsoft Excel
version 97 (8.0) or higher.
Model assumptions
As stated in the introduction, the purpose of this thesis is to examine the use of
Monte Carlo computer simulation for understanding risk factors associated with
childhood overweight. As such, it is hoped that future research will build and ultimately
improve upon the presented concepts. Even the most robust and extensively developed
models contain uncertainties and error. All simulation models have the potential for
improvement. That said, simulation is built on probability theory and mathematics.
Computer modeling is a statistically viable tool for modeling real-life situations and for
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studying how stochastic systems work. “Stochastic” is a term meaning to have a random
variable. A stochastic model is a tool for estimating potential outcomes by allowing for
random variation. The more accurate the model, the better the model is in predicting
outcomes.
In accordance with the scope and purpose of this thesis, the following
assumptions apply:
•
•

•
•

The model is subject to limitations in population sample sizes, sampling error and
aggregation of data for ages 5-10 years and 11-17 years.
The model collapses probabilities from Freedman et. al. into specific risk factor
categories and does not account for the complexities of relationships that exist
between risk factors. The purpose of this model is to illustrate the benefits in
simulating cardiovascular risk factors among overweight children and adolescents
and does not seek to explain all relationships that may exist between data points.
The model is limited by the generalizations of calculating trend lines and in using
quetelet index ranges for each predicted cardiovascular risk factor.
The Monte Carlo simulation is performed for five iterations of 1,000 trials.
Therefore, each simulation is limited to a total of 5,000 trials. This number of
trials is assumed sufficient in achieving the Law of Large Numbers. Additionally,
each iteration utilizes a different algorithm for generating numbers and therefore
achieves greater randomness.

Model inputs
Thompson, Burmaster and Crouch are pioneers in the work of utilizing Monte
Carlo techniques for quantifying uncertainty in public health risk assessments.
According to their work:
“The first step in the Monte Carlo simulation is to determine (continuous or
discrete) probability distribution functions (PDFs) to describe each of the variable
in the uncertainty analysis. In the simulation, each of many input variables can
become a random variable with known or estimated PDF [or equivalently, a
cumulative distribution function (CDF)]. Within this framework, a variable takes
on a range of values with a known probability. Some distributions, for instance,
are based on normal human variability and they come into play in the uncertainty
analysis because we are uncertain who the person is that will actually be
following the scenario”(Thompson, Burmaster, Crouch, 1992, p54).
In this model, two separate PDFs are developed and applied for obtaining quetelet index
values (i.e., children ages 5-10 years of age and adolescents 11-17 years of age). The
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quetelet index PDF utilizes a histogram of probabilities from the Bogalusa Heart Study
(Table 4).
Table 4 BMI Probability Distribution (ages 5-10)

BMI Range
0 =< x < 25
25 =< x < 50
50 =< x < 75
75 =< x < 85
85 =< x < 95
95 =< x < 97
97 =< x < 100

Frequency
of
Occurrence
904
817
798
340
384
100
256

Range

Probability
for Range

Probability
per Percentile

25
25
25
10
10
2
3

0.2512
0.2270
0.2217
0.0945
0.1067
0.0278
0.0711

0.0100
0.0091
0.0089
0.0094
0.0107
0.0139
0.0237

Similar a histogram is created for adolescents ages 11-17 using probabilities established
from the Bogalusa Heart Study.
Table 5 BMI Probability Distribution (ages 11-17)

BMI Range
0 =< x < 25
25 =< x < 50
50 =< x < 75
75 =< x < 85
85 =< x < 95
95 =< x < 97
97 =< x < 100

Frequency
of
Occurrence
1189
1122
1249
611
763
210
424

Range

Probability
for Range

Probability
per Percentile

25
25
25
10
10
2
3

0.2135
0.2015
0.2243
0.1097
0.1370
0.0377
0.0761

0.0085
0.0081
0.0090
0.0110
0.0137
0.0189
0.0254

Cardiovascular risk factors of childhood and adolescent overweight
The cardiovascular risk factor model, will direct each trial or randomly generated
individual through a second series of equations. The equations determine the individual’s
probability for being “at risk” of cardiovascular disease based on a particular risk factor.
Using regression analysis, polynomial equations are derived to explain the
relationship between quetelet index and the probability of being at risk for cardiovascular
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disease due to a particular risk factor. Cardiovascular risk factors in scope for this
analysis include:
•
•
•
•
•
•
•

Total Cholesterol > 200 mg/dL
Triglycerides > 130 mg/dL
Low-Density Lipoprotein Cholesterol > 130 mg/dL
High-Density Lipoprotein Cholesterol < 35 mg/dL
Fasting Insulin > 95th Percentile
Systolic Blood Pressure > 95th Percentile
Diastolic Blood Pressure > 95th Percentile

Utilizing probabilities from Freedman et al. polynomial equations are developed
to represent the relationships between BMI and cardiovascular risk factor probabilities.
Figures IV-1 and IV-2 show the relationship of quetelet index (or BMI) in children and
adolescents to the probability of total cholesterol exceeding 200 mg/dL.
Figure IV-1 Relationship of quetelet index in children ages 5-10 to probability of total cholesterol >
200 mg/dL
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Figure IV-2 Relationship of quetelet index in children ages 11-17 to probability of total cholesterol >
200 mg/dL

Likewise, Equations 3 through 16 show the relationships for each cardiovascular risk
factor by age group. . Graphs for each equation are also available in Appendix E.
Equation 3 - Probability of at risk for total cholesterol as a function of quetelet index (ages 5-10)

y = 0.0000300x2 - 0.0020978x + 0.1188745
x = probability of total cholesterol > 200 mg/dL; y = quetelet index
Equation 4 - Probability of at risk for total cholesterol as a function of quetelet index (ages 11-17)

y = 0.0000286x2 - 0.0020420x + 0.0857550
x = probability of total cholesterol > 200 mg/dL; y = quetelet index
Equation 5 - Probability of at risk for triglycerides as a function of quetelet index (ages 5-10)

y = 0.0000401x2 - 0.0030472x + 0.0633072
x = probability of Triglycerides > 130 mg/dL; y = quetelet index
Equation 6 - Probability of at risk for triglycerides as a function of quetelet index (ages 11-17)

y = 0.0000677x2 - 0.0053929x + 0.1072561
x = probability of Triglycerides > 130 mg/dL; y = quetelet index
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Equation 7 - Probability of at risk for Low-Density Lipoprotein Cholesterol as a function of quetelet
index (ages 5-10)

y = 0.0000315x2 - 0.0023502x + 0.1106534
x = probability of Low-Density Lipoprotein Cholesterol > 130 mg/dL; y = quetelet index
Equation 8 - Probability of at risk for Low-Density Lipoprotein Cholesterol as a function of quetelet
index (ages 11-17)

y = 0.0000335x2 - 0.0022955x + 0.0687305
x = probability of Low-Density Lipoprotein Cholesterol > 130 mg/dL; y = quetelet index
Equation 9 - Probability of at risk for High-Density Lipoprotein Cholesterol as a function of quetelet
index (ages 5-10)

y = 0.0000283x2 - 0.0024594x + 0.0859913
x = probability of High-Density Lipoprotein Cholesterol < 35 mg/dL; y = quetelet index
Equation 10 - Probability of at risk for High-Density Lipoprotein Cholesterol as a function of
quetelet index (ages 11-17)

y = 0.0000187x2 - 0.0007838x + 0.0752449
x = probability of High-Density Lipoprotein Cholesterol < 35 mg/dL; y = quetelet index
Equation 11 - Probability of at risk for Fasting Insulin as a function of quetelet index (ages 5-10)

y = 0.0000582x2 - 0.0050417x + 0.0931682
x = probability of Fasting Insulin > 95th Percentile; y = quetelet index
Equation 12 - Probability of at risk for Fasting Insulin as a function of quetelet index (ages 11-17)

y = 0.0000548x2 - 0.0045987x + 0.0760686
x = probability of Fasting Insulin > 95th Percentile; y = quetelet index
Equation 13 - Probability of at risk for Systolic Blood Pressure as a function of quetelet index (ages
5-10)

y = 0.0000435x2 - 0.0033672x + 0.0661171
x = probability of Systolic Blood Pressure > 95th Percentile; y = quetelet index
Equation 14 - Probability of at risk for Systolic Blood Pressure as a function of quetelet index (ages
11-17)

y = 0.0000042x2 + 0.0001590x + 0.0217240
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x = probability of Systolic Blood Pressure > 95th Percentile; y = quetelet index
Equation 15 - Probability of at risk for Diastolic Blood Pressure as a function of quetelet index (ages
5-10)

y = 0.0000183x2 - 0.0009286x + 0.0290296
x = probability of Diastolic Blood Pressure > 95th Percentile; y = quetelet index
Equation 16 - Probability of at risk for Diastolic Blood Pressure as a function of quetelet index (ages
11-17)

y = 0.0000037x2 - 0.0002198x + 0.0460476
x = probability of Diastolic Blood Pressure > 95th Percentile; y = quetelet index
High levels of insulin, systolic blood pressure and diastolic blood pressure were
defined as those with greater than the 95th percentile for race, sex and age specific
national standards.
Model outputs
Now that the model inputs are defined, Figures IV-3 and IV-4 provides an
overview for the model architecture.
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Figure IV-3 Cardiovascular Risk Factor Model (age 5-10)
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Figure IV-4 Cardiovascular Risk Factor Model (age 11-17)
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Once the risk factor probabilities are established for an individual based on
quetelet index, a uniform distribution is utilized as a comparison constant. In other
words, say the probability for an individual being “at risk” due to total cholesterol is 0.25.
A uniform distribution from 0.00 to 1.00 will randomly select a comparison constant. If
the comparison constant is .36, then the individual in not “at risk” for total cholesterol
(i.e., .36 > .25). If, however, the comparison constant were .19 the individual would be at
risk for total cholesterol (i.e., .19 < .25).
Two additional outputs of the model include:
•

Proportion of children and adolescents who are “At Risk for Overweight” but
not “Overweight”. Children and adolescents with a quetelet index greater
than 85% but less than 95% (see Appendix A) are defined as “At Risk for
Overweight” but not “Overweight”.

•

Proportion of children and adolescents who are “Overweight”. Children and
adolescents with a quetelet index greater than 95% (see Appendix A) are
defined as “Overweight”.

V. Discussion
Simulation results for adolescents 5 to 10 years of age.
The results from the first simulation model (Figure IV-3) for children ages 5 to 10
are provided in Tables 6 through 9. Total number of occurrences and percentages are
shown for all trials (Table 6), children with BMI < 85th percentile (Table 7), children with
BMI between the 85th and 95th percentiles (Table 8), and children with BMI > 95th
percentile (Table 9).
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Table 6 Simulation results for all children ages 5 to 10 years
Simulation results for all children ages 5 to 10 years
Yes
No
Total
Children "at risk for overweight" but who are not "overweight"
Children who are "overweight"
Total Cholesterol > 200 mg/dL?
Triglycerides > 130 mg/dL?
Low-Density Lipoprotein Cholesterol > 130 mg/dL?
High-Density Lipoprotein Cholesterol < 35 mg/dL?
Fasting Insulin > 95th Percentile?
Systolic Blood Pressure > 95th Percentile?
Diastolic Blood Pressure > 95th Percentile?

624
383
645
276
540
322
244
259
212

4376
4617
4355
4724
4460
4678
4756
4741
4788

5000
5000
5000
5000
5000
5000
5000
5000
5000

Percent
12.48%
7.66%
12.90%
5.52%
10.80%
6.44%
4.88%
5.18%
4.24%

Table 7 Simulation results for healthy weight (quetelet index < 85th) children ages 5 to 10 years
Simulation results for healthy weight (quetelet index < 85th)
years
Yes
Total Cholesterol > 200 mg/dL?
455
Triglycerides > 130 mg/dL?
155
Low-Density Lipoprotein Cholesterol > 130 mg/dL?
367
High-Density Lipoprotein Cholesterol < 35 mg/dL?
221
Fasting Insulin > 95th Percentile?
114
Systolic Blood Pressure > 95th Percentile?
106
Diastolic Blood Pressure > 95th Percentile?
106

children ages 5 to 10
No
3538
3838
3626
3772
3879
3887
3887

Total
3993
3993
3993
3993
3993
3993
3993

Percent
11.39%
3.88%
9.19%
5.53%
2.85%
2.65%
2.65%

Table 8 Simulation results for "At risk for overweight" but not "Overweight" (85th < quetelet index
< 95th) children ages 5 to 10 years
Simulation results for "At risk for overweight" but not "Overweight" (85th <
quetelet index < 95th) children ages 5 to 10 years
Yes No Total Percent
Total Cholesterol > 200 mg/dL?
114 510
624
18.27%
Triglycerides > 130 mg/dL?
66 558
624
10.58%
Low-Density Lipoprotein Cholesterol > 130 mg/dL?
100 524
624
16.03%
High-Density Lipoprotein Cholesterol < 35 mg/dL?
48 576
624
7.69%
Fasting Insulin > 95th Percentile?
72 552
624
11.54%
Systolic Blood Pressure > 95th Percentile?
91 533
624
14.58%
Diastolic Blood Pressure > 95th Percentile?
62 562
624
9.94%
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Table 9 Simulation results for "Overweight" (quetelet index > 95th) children ages 5 to 10 years
Simulation results for "Overweight" (quetelet index > 95th) children ages
years
Yes No Total
Total Cholesterol > 200 mg/dL?
76 307
383
Triglycerides > 130 mg/dL?
55 328
383
Low-Density Lipoprotein Cholesterol > 130 mg/dL?
73 310
383
High-Density Lipoprotein Cholesterol < 35 mg/dL?
53 330
383
Fasting Insulin > 95th Percentile?
58 325
383
Systolic Blood Pressure > 95th Percentile?
62 321
383
Diastolic Blood Pressure > 95th Percentile?
44 339
383

5 to 10
Percent
19.84%
14.36%
19.06%
13.84%
15.14%
16.19%
11.49%

A comparison of Tables 6 through 9, concludes that the percentage of children “at
risk” for various cardiovascular risk factors increased with each increasing level of
severity in weight status. What’s more, a status of “healthy weight” showed significant
reduction in occurrence of cardiovascular risk factors.
Tables 10 and 11 provide a summary of the results from the simulation model and
the Bogalusa Heart Study. A comparison of Tables 16 and 17 provides an example of the
level of variation experienced in computer simulation.
Table 10 Simulation results for children ages 5 to 10 years
Simulation results for children ages 5 to 10 years
All
BMI

BMI<85th

85th<BMI<95th

12.90%

11.39%

18.27%

19.84%

5.52%

3.88%

10.58%

14.36%

Low-Density Lipoprotein Cholesterol > 130 mg/dL?

10.80%

9.19%

16.03%

19.06%

High-Density Lipoprotein Cholesterol < 35 mg/dL?

6.44%

5.53%

7.69%

13.84%

Fasting Insulin > 95th Percentile?

4.88%

2.85%

11.54%

15.14%

Systolic Blood Pressure > 95th Percentile?

5.18%

2.65%

14.58%

16.19%

Diastolic Blood Pressure > 95th Percentile?

4.24%

2.65%

9.94%

11.49%

Total Cholesterol > 200 mg/dL?
Triglycerides > 130 mg/dL?
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BMI>95th

Table 11 Bogalusa Heart Study results for children ages 5 to 10 years
Bogalusa Heart Study results for children ages 5 to 10 years
All
BMI
BMI<85th 85th<BMI<95th
Total Cholesterol > 200 mg/dL?

BMI>95th

12.01%

10.04%

18.00%

21.31%

5.25%

3.04%

10.00%

17.91%

Low-Density Lipoprotein Cholesterol > 130 mg/dL?

10.66%

8.52%

18.00%

19.91%

High-Density Lipoprotein Cholesterol < 35 mg/dL?

6.43%

5.16%

8.00%

14.91%

Fasting Insulin > 95th Percentile?

4.53%

2.40%

4.00%

22.22%

Systolic Blood Pressure > 95th Percentile?

5.06%

3.03%

7.00%

19.19%

Diastolic Blood Pressure > 95th Percentile?

4.69%

3.39%

7.00%

12.60%

Triglycerides > 130 mg/dL?

Utilizing the results from Tables 6 through 9 several implications can be made
that are relevant for addressing overweight in children and adolescents in the future. The
sensitivity analysis provided in Figures V-1 and V-2 show the risk factors that are most
sensitive to weight status. Particularly, Figure V-1 shows the sensitivity of risk factors by
healthy weight status (BMI less than 85th percentile) and “at risk of overweight” status
(BMI between 85th and 95th percentiles).
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Figure V-1 Sensitivity analysis of risk factors by simulated percentage at risk (ages 5-10)

Sensitivity analysis of risk factors (ages 5-10)
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First, the most sensitive risk factor appears to be systolic blood pressure (SBP).
This is identified because of the steep slope of the SBP line. Based on this finding,
public health professionals may infer that interventions aimed at SBP levels in
overweight children are most critical (because of the sensitivity to weight status).
However, this assumption should be weighted against the significance that SBP has on
specific outcomes such as cardiovascular disease.
Second, risk for total cholesterol (TC) levels has the highest percentages for both
“healthy weight” children as well as children with a weight status of “at risk for
overweight”, but not “overweight”. This may indicate the criticality for public health
professionals to create interventions for addressing total cholesterol levels in children of
all weight statuses. Here again, this decision should be weighed against the significance
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of total cholesterol on specific outcomes such as cardiovascular disease. However, it is
clear that Monte Carlo simulation in conjunction with tools such as sensitivity analysis
provide the means for gaining insight into the relationships between cardiovascular risk
factors and child and adolescent BMI.
Next, a similar sensitivity analysis is performed to examine the sensitivity of risk
factors by weight status for “at risk of overweight” (BMI between 85th and 95th
percentiles) and “overweight” (BMI greater than 95th percentile) children.
Figure V-2 Sensitivity analysis of risk factors by simulated percentage at risk (ages 5-10)

Sensitivity analysis of risk factors (ages 5-10)

Simulated % of children at risk
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From this graph, it is interesting to note that high-density lipoprotein cholesterol (HDLP)
has the smallest slope value in Figure V-1 but has the steepest slope in Figure V-2. This
may indicate a need for creating interventions aimed at aimed at improving HDLP levels
in children who have a BMI greater than the 95th percentile.
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Simulation results for adolescents 11 to 17 years of age.
The results from the second simulation model (Figure IV-4) for adolescents ages
11 to 17 are provided in Tables 12 through 15. Total number of occurrences and
percentages are shown for all trials (Table 12), adolescents with BMI < 85th percentile
(Table 13), adolescents with BMI between the 85th and 95th percentiles (Table 14), and
adolescents with BMI > 95th percentile (Table 15).
Table 12 Simulation results for all adolescents ages 11 to 17 years
Simulation results for all adolescents ages 11 to
Yes
Adolescents "at risk for overweight" but who are not
"overweight"
772
Adolescents who are "overweight"
569
Total Cholesterol > 200 mg/dL?
463
Triglycerides > 130 mg/dL?
447
Low-Density Lipoprotein Cholesterol > 130 mg/dL?
403
High-Density Lipoprotein Cholesterol < 35 mg/dL?
548
Fasting Insulin > 95th Percentile?
241
Systolic Blood Pressure > 95th Percentile?
233
th
Diastolic Blood Pressure > 95 Percentile?
250

17 years
No
Total
4228
4431
4537
4553
4597
4452
4759
4767
4750

5000
5000
5000
5000
5000
5000
5000
5000
5000

Percent
15.44%
11.38%
9.26%
8.94%
8.06%
10.96%
4.82%
4.66%
5.00%

Table 13 Simulation results for healthy weight (quetelet index < 85th) adolescents ages 11 to 17 years
Simulation results for healthy weight (quetelet index < 85th)
to 17 years
Yes
Total Cholesterol > 200 mg/dL?
260
Triglycerides > 130 mg/dL?
191
Low-Density Lipoprotein Cholesterol > 130 mg/dL?
199
High-Density Lipoprotein Cholesterol < 35 mg/dL?
334
Fasting Insulin > 95th Percentile?
64
Systolic Blood Pressure > 95th Percentile?
139
Diastolic Blood Pressure > 95th Percentile?
173

adolescents ages 11
No
3399
3468
3460
3325
3595
3520
3486

Total
3659
3659
3659
3659
3659
3659
3659
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Percent
7.11%
5.22%
5.44%
9.13%
1.75%
3.80%
4.73%

Table 14 Simulation results for "At risk for overweight" but not "Overweight" (85th < quetelet
index < 95th) adolescents ages 11 to 17 years
Simulation results for "At risk for overweight" but not "Overweight" (85th <
quetelet index < 95th) adolescents ages 11 to 17 years
Yes No Total Percent
Total Cholesterol > 200 mg/dL?
101 671
772
13.08%
Triglycerides > 130 mg/dL?
129 643
772
16.71%
Low-Density Lipoprotein Cholesterol > 130 mg/dL?
110 662
772
14.25%
High-Density Lipoprotein Cholesterol < 35 mg/dL?
123 649
772
15.93%
Fasting Insulin > 95th Percentile?
78 694
772
10.10%
Systolic Blood Pressure > 95th Percentile?
50 722
772
6.48%
Diastolic Blood Pressure > 95th Percentile?
37 735
772
4.79%
Table 15 Simulation results for "Overweight" (quetelet index > 95th) adolescents ages 11 to 17 years
Simulation results for "Overweight" (quetelet index > 95th) adolescents ages 11 to
17 years
Yes No Total Percent
Total Cholesterol > 200 mg/dL?
102 467
569
17.93%
Triglycerides > 130 mg/dL?
127 442
569
22.32%
Low-Density Lipoprotein Cholesterol > 130 mg/dL?
94 475
569
16.52%
High-Density Lipoprotein Cholesterol < 35 mg/dL?
91 478
569
15.99%
Fasting Insulin > 95th Percentile?
99 470
569
17.40%
Systolic Blood Pressure > 95th Percentile?
44 525
569
7.73%
Diastolic Blood Pressure > 95th Percentile?
40 529
569
7.03%

A comparison of Tables 12 through 15, concludes that the percentage of
adolescents “at risk” for various cardiovascular risk factors increased with each
increasing level of severity in weight status. Again, a status of “healthy weight” showed
significant reduction in occurrence of cardiovascular risk factors.
Tables 16 and 17 provide a summary of the results from the simulation model and
the Bogalusa Heart Study. A comparison of Tables 16 and 17 provides an example of the
level of variation experienced in computer simulation.
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Table 16 Simulation results for adolescents ages 11 to 17 years
Simulation results for adolescents ages 11 to 17 years
All
BMI

BMI<85th

85th<BMI<95th

BMI>95th

Total Cholesterol > 200 mg/dL?

9.26%

7.11%

13.08%

17.93%

Triglycerides > 130 mg/dL?

8.94%

5.22%

16.71%

22.32%

Low-Density Lipoprotein Cholesterol > 130 mg/dL?

8.06%

5.44%

14.25%

16.52%

High-Density Lipoprotein Cholesterol < 35 mg/dL?

10.96%

9.13%

15.93%

15.99%

4.82%

1.75%

10.10%

17.40%

Systolic Blood Pressure > 95th Percentile?

4.66%

3.80%

6.48%

7.73%

Diastolic Blood Pressure > 95th Percentile?

5.00%

4.73%

4.79%

7.03%

Fasting Insulin > 95th Percentile?

Table 17 Bogalusa Heart Study results for adolescents ages 11 to 17 years
Bogalusa Heart Study results for adolescents ages 11 to 17 years
All
BMI

BMI<85th

85th<BMI<95th

BMI>95th

Total Cholesterol > 200 mg/dL?

9.00%

6.74%

15.00%

16.68%

Triglycerides > 130 mg/dL?

8.10%

4.45%

12.00%

27.36%

Low-Density Lipoprotein Cholesterol > 130 mg/dL?

7.83%

5.33%

13.00%

18.02%

High-Density Lipoprotein Cholesterol < 35 mg/dL?

10.78%

8.88%

14.00%

19.34%

Fasting Insulin > 95th Percentile?

4.27%

1.75%

5.00%

20.03%

Systolic Blood Pressure > 95th Percentile?

5.00%

4.03%

7.00%

9.01%

Diastolic Blood Pressure > 95th Percentile?

4.92%

4.71%

4.00%

7.34%

Figure V-3 provides a sensitivity analysis of risk factors by healthy weight status
(BMI less than 85th percentile) and “at risk of overweight” status (BMI between 85th and
95th percentiles) for ages 11-17.
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Figure V-3 Sensitivity analysis of risk factors by simulated percentage at risk (ages 11-17)

Sensitivity analysis of risk factors (ages 11-17)
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From this graph, triglycerides had not only the steepest slope but also the highest
percentage of at risk adolescents between the ages of 11 to 17 when moving from a status
of “health weight” to “at risk for overweight” but not ‘overweight”. Based on this
finding, public health professionals may need to focus more attention on intervention for
reducing triglyceride levels in adolescents between the ages of 11 to 17.
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Figure V-4 Sensitivity analysis of risk factors by simulated percentage at risk (ages 11-17)

Sensitivity analysis of risk factors (ages 11-17)
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Based on the sensitivity analysis in Figure V-4, triglycerides, again, have the
highest percentage of “at risk” 11 to 17 year olds. It is also interesting to note that the
percentage of adolescents at risk for High-Density Lipoprotein Cholesterol (HDLC) has
almost no change when moving from children who are “at risk of overweight” but not
“overweight’ to a status of “overweight”. This may indicate an opportunity for public
health professionals to focus resources on interventions that target other risk factors for
children. However, this decision should only be made after considering variables such as
the weighted impact HDLC has on outcomes such as cardiovascular disease when
compared to other risk factors.
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Multiple risk factor analysis
Utilizing the results from the previous section, a multiple risk factor analysis is
performed to illustrate how Monte Carlo simulation can provide insight into co-existence
of risk factors as a result of BMI. Analysis is performed separately for children and
adolescents.
Total number of co-existing risk factors for children 5 to 10 years of age
Graphs showing frequency by number of co-existing cardiovascular risk factors
are presented separately for all children ages 5 to 10 (Figure V-5), children of “healthy
weight” ages 5 to 10 (Figure V-6), children “at risk for overweight” ages 5 to 10 (Figure
V-7), and “overweight” children ages 5 to 10 (Figure V-8). It is important to note that
each graph utilizes a different scale for the y-axis. Additionally, each graph utilizes a
different sample size making the percentage of children with multiple risk factors the
most significant measure of comparison.
Figure V-5 Total number of co-existing risk factors for children ages 5 to 10 (combined weight status
n=5,000)
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Figure V-6 Total number of co-existing risk factors for children ages 5 to 10 who are not “at risk for
overweight” or “overweight” (n=3993)
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Figure V-7 Total number of co-existing risk factors for children "at risk for overweight” but who are
not “overweight” ages 5 to 10 (n=624)
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Figure V-8 Total number of co-existing risk factors for children who are "overweight" ages 5 to 10
(n=383)
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After comparing Figures V-5 through V-8, the proportion of children with coexisting risk factors increased with each increasing level of severity in weight status.
What’s more, a status of “healthy weight” showed significant reduction in occurrence of
cardiovascular risk factors.
Total number of co-existing risk factors for children 11 to 17 years of age.
Graphs showing frequency by number of co-existing cardiovascular risk factors
are presented separately for all adolescents ages 11 to 17 (Figure V-9), adolescents of
“healthy weight” ages 11 to 17 (Figure V-10), adolescents “at risk for overweight” ages
11 to 17 (Figure V-11), and “overweight” adolescents ages 11 to 17 (Figure V-12). It is
important to note that each graph utilizes a different scale for the y-axis. Additionally,
each graph utilizes a different sample size making the percentage of children with
multiple risk factors the most significant measure of comparison.
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Figure V-9 Total number of co-existing risk factors for adolescents ages 11 to 17 (combined weight
status n=5,000)
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Figure V-10 Total number of coexisting risk factors for adolescents ages 11 to 17 who are not “at risk
for overweight” or “overweight” (n=3659)
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Figure V-11 Total number of coexisting risk factors for adolescents "at risk for overweight” but who
are not “overweight” ages 11 to 17 (n=772)
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Figure V-12 Total number of coexisting risk factors for adolescents who are "overweight" ages 11 to
17 (n=569)
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After comparing Figures 7-5 through 7-8, the proportion of adolescents with coexisting risk factors increased with each increasing level of severity in weight status.
Again, a status of “healthy weight” showed significant reduction in occurrence of
cardiovascular risk factors.
Changes in risk factors due to controlled BMI
This next section examines how cardiovascular risk factors in children and
adolescents may change with changes in BMI.
A new model is now constructed assuming that child and adolescent BMI levels
return to recommended standards as presented by the CDC growth charts released in May
of 2000 (see Appendix A). The new model is modified to predict child and adolescent
BMI patterns utilizing a histogram of CDC recommended BMI levels. The model
assumes that all relationships between quetelet index and the probabilities of having a
specific cardiovascular risk factor will remain as defined within the original model.
Under the revised model (i.e., 2000 distribution), two new simulations are
performed of 5,000 Monte Carlo trials.
Results for children 5 to 10 years of age under the 2000 distribution model
The first simulation is performed for children ages 5 to 10. Totals of weight
status and individual risk factors are presented separately for all children ages 5 to 10
(Table 18), children of “healthy weight” ages 5 to 10 (Table 19), children “at risk for
overweight” ages 5 to 10 (Table 20), and “overweight” children ages 5 to 10 (Table
21).
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Table 18 Simulation results for all children ages 5 to 10 years (2000 distribution model)
Simulation results for all children ages 5 to 10 years
Yes
No
Total
Children "at risk for overweight" but who are not "overweight"
Children who are "overweight"
Total Cholesterol > 200 mg/dL?
Triglycerides > 130 mg/dL?
Low-Density Lipoprotein Cholesterol > 130 mg/dL?
High-Density Lipoprotein Cholesterol < 35 mg/dL?
Fasting Insulin > 95th Percentile?
Systolic Blood Pressure > 95th Percentile?
Diastolic Blood Pressure > 95th Percentile?

486
214
615
228
512
312
190
212
219

4514
4786
4385
4772
4488
4688
4810
4788
4781

5000
5000
5000
5000
5000
5000
5000
5000
5000

Percent
9.72%
4.28%
12.30%
4.56%
10.24%
6.24%
3.80%
4.24%
4.38%

Table 19 Simulation results for healthy weight (quetelet index < 85th) children ages 5 to 10 years
(2000 distribution model)
Simulation results for healthy weight (quetelet index < 85th)
years
Yes
Total Cholesterol > 200 mg/dL?
474
Triglycerides > 130 mg/dL?
140
Low-Density Lipoprotein Cholesterol > 130 mg/dL?
392
High-Density Lipoprotein Cholesterol < 35 mg/dL?
229
Fasting Insulin > 95th Percentile?
112
Systolic Blood Pressure > 95th Percentile?
125
Diastolic Blood Pressure > 95th Percentile?
152

children ages 5 to 10
No
3826
4160
3908
4071
4188
4175
4148

Total
4300
4300
4300
4300
4300
4300
4300

Percent
11.02%
3.26%
9.12%
5.33%
2.60%
2.91%
3.53%

Table 20 Simulation results for "At risk for overweight" but not "Overweight" (85th < quetelet
index < 95th) children ages 5 to 10 years (2000 distribution model)
Simulation results for "At risk for overweight" but not "Overweight" (85th <
quetelet index < 95th) children ages 5 to 10 years
Yes No Total Percent
Total Cholesterol > 200 mg/dL?
88 398
486
18.11%
Triglycerides > 130 mg/dL?
54 432
486
11.11%
Low-Density Lipoprotein Cholesterol > 130 mg/dL?
86 400
486
17.70%
High-Density Lipoprotein Cholesterol < 35 mg/dL?
58 428
486
11.93%
Fasting Insulin > 95th Percentile?
49 437
486
10.08%
Systolic Blood Pressure > 95th Percentile?
56 430
486
11.52%
Diastolic Blood Pressure > 95th Percentile?
39 447
486
8.02%
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Table 21 Simulation results for "Overweight" (quetelet index > 95th) children ages 5 to 10 years
(2000 distribution model)
Simulation results for "Overweight" (quetelet index > 95th) children ages
years
Yes No Total
Total Cholesterol > 200 mg/dL?
53 161
214
Triglycerides > 130 mg/dL?
34 180
214
Low-Density Lipoprotein Cholesterol > 130 mg/dL?
34 180
214
High-Density Lipoprotein Cholesterol < 35 mg/dL?
25 189
214
Fasting Insulin > 95th Percentile?
29 185
214
Systolic Blood Pressure > 95th Percentile?
31 183
214
Diastolic Blood Pressure > 95th Percentile?
28 186
214

As was expected, a comparison of Tables 18 through 21 conclude that the
percentage of children “at risk” for various cardiovascular risk factors increased with
each increasing level of severity in weight status. Sensitivity for any particular risk factor
may be assessed by comparing the degree of change between original and revised
models. Figures V-13 through V-15 show side-by-side comparisons to illustrate the
impact of reduced BMI on weight status, total cholesterol and co-existence of three
cardiovascular risk factors. Graphs for each specific risk factor as well as greater
breakdowns in evaluating the co-existence of risk factors for each age group are available
in Appendix F.
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5 to 10
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Figure V-13 Simulation comparison- Children ages 5 to 10 by weight status
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Figure V-14 Simulation comparison- Children ages 5 to 10 w/ total cholesterol > 200 mg/dL
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Figure V-15 Simulation comparison- Children ages 5 to 10 w/ 3 out of 7 risk factors
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Results for adolescents 11 to 17 years of age under the 2000 distribution model
The next simulation is performed for adolescents ages 11 to 17. Totals of
weight status and individual risk factors are presented separately for all adolescents
ages 11 to 17 (Table 22), adolescents of “healthy weight” ages 11 to 17 (Table 23),
adolescents “at risk for overweight” ages 11 to 17 (Table 24), and “overweight”
adolescents ages 11 to 17 (Table 25).
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Table 22 Simulation results for all children ages 11 to 17 years (2000 distribution model)
Simulation results for all adolescents ages 11 to
Yes
Adolescents "at risk for overweight" but who are not
504
"overweight"
Children who are "overweight"
212
Total Cholesterol > 200 mg/dL?
371
Triglycerides > 130 mg/dL?
317
Low-Density Lipoprotein Cholesterol > 130 mg/dL?
348
High-Density Lipoprotein Cholesterol < 35 mg/dL?
525
Fasting Insulin > 95th Percentile?
194
Systolic Blood Pressure > 95th Percentile?
219
Diastolic Blood Pressure > 95th Percentile?
217

17 years
No
Total
4496
4788
4629
4683
4652
4475
4806
4781
4783

5000
5000
5000
5000
5000
5000
5000
5000
5000

Percent
10.08%
4.24%
7.42%
6.34%
6.96%
10.50%
3.88%
4.38%
4.34%

Table 23 Simulation results for healthy weight (quetelet index < 85th) children ages 11 to 17 years
(2000 distribution model)
Simulation results for healthy weight (quetelet index < 85th)
to 17 years
Yes
Total Cholesterol > 200 mg/dL?
288
Triglycerides > 130 mg/dL?
171
Low-Density Lipoprotein Cholesterol > 130 mg/dL?
231
High-Density Lipoprotein Cholesterol < 35 mg/dL?
399
Fasting Insulin > 95th Percentile?
91
Systolic Blood Pressure > 95th Percentile?
160
Diastolic Blood Pressure > 95th Percentile?
167

adolescents ages 11
No
3994
4111
4051
3883
4191
4122
4115

Total
4282
4282
4282
4282
4282
4282
4282

Percent
6.73%
3.99%
5.39%
9.32%
2.13%
3.74%
3.90%

Table 24 Simulation results for "At risk for overweight" but not "Overweight" (85th < quetelet
index < 95th) children ages 11 to 17 years (2000 distribution model)
Simulation results for "At risk for overweight" but not "Overweight" (85th <
quetelet index < 95th) adolescents ages 11 to 17 years
Yes No Total Percent
Total Cholesterol > 200 mg/dL?
53 451
504
10.52%
Triglycerides > 130 mg/dL?
106 398
504
21.03%
Low-Density Lipoprotein Cholesterol > 130 mg/dL?
72 432
504
14.29%
High-Density Lipoprotein Cholesterol < 35 mg/dL?
88 416
504
17.46%
Fasting Insulin > 95th Percentile?
69 435
504
13.69%
Systolic Blood Pressure > 95th Percentile?
32 472
504
6.35%
Diastolic Blood Pressure > 95th Percentile?
31 473
504
6.15%
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Table 25 Simulation results for "Overweight" (quetelet index > 95th) children ages 11 to 17 years
(2000 distribution model)
Simulation results for "Overweight" (quetelet index > 95th) adolescents ages 11 to
17 years
Yes No Total Percent
Total Cholesterol > 200 mg/dL?
30 184
214
14.02%
Triglycerides > 130 mg/dL?
40 174
214
18.69%
Low-Density Lipoprotein Cholesterol > 130 mg/dL?
45 169
214
21.03%
High-Density Lipoprotein Cholesterol < 35 mg/dL?
38 176
214
17.76%
Fasting Insulin > 95th Percentile?
34 180
214
15.89%
Systolic Blood Pressure > 95th Percentile?
27 187
214
12.62%
Diastolic Blood Pressure > 95th Percentile?
19 195
214
8.88%

Similar to the previous analysis, a comparison of Tables 22 through 25 concludes
that the percentage of adolescents “at risk” for various cardiovascular risk factors
increased with each increasing level of severity in weight status. Figures V-16 through
V-18 show side-by-side comparisons to illustrate the impact of reduced BMI on weight
status, total cholesterol and co-existence of three cardiovascular risk factors. Graphs for
each specific risk factor as well as greater breakdowns in evaluating the co-existence of
risk factors for each age group are available in Appendix F.
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Figure V-16 Simulation comparison- Children ages 11 to 17 by weight status
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Figure V-17 Simulation comparison- Children ages 11 to 17 w/ total cholesterol > 200 mg/dL
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Figure V-18 Simulation comparison- Children ages 11 to 17 w/ 3 out of 7 risk factors
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Study limitations and future opportunities
Although simulation is a valuable tool in strategy development, it does present a
number of limitations. First and foremost, all simulation models are restricted to the
principles of “garbage in: garbage out”. A model is only as good as the probabilities used
in its design. The model presented in this thesis was designed using probabilities from
the Bogalusa Heart Study. It is important to note that the population used in this study
comes from a region of the U.S. that is more likely to be at risk for overweight. The
potential exists to improve model accuracy by combining data from other studies to
create larger data sets and more accurate probabilities.
The study population was limited to 43,000 (1/3 black, 2/3 white) schoolchildren
between the ages of 5 and 17 years. Analysis was restricted to individuals who properly
fasted and who had recorded values for weight, height, total cholesterol and systolic
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blood pressure. The resulting sample was restricted to a sample size of 9,167
schoolchildren between the ages of 5 and 17 years.
Additional limitations include the following:
Accuracy of BMI readings - BMI is a good tool for broad categorization of populations
for statistical purposes. That said, BMI does come with limitations. Distortions to this
index may be attributed to factors such as fitness level, muscle mass, bone structure,
gender and ethnicity.
Sampling error - The model is subject to limitations in population sample sizes and
aggregation of data for ages 5-10 and 11-17 years. Additionally, the revised simulation
model presented in Chapter V utilizes the same polynomial equations for cardiovascular
risk factors derived from the original probabilities obtained through the Bogalusa Heart
Study. This generalization may contribute to larger sampling error.
Relationships between risk factors - The model treats each risk factor independently and
does not account for the complexities of relationships that exist between risk factors. It is
outside the scope of this paper to explain all relationships that may exist between data
points.
Regression analysis - The model is limited by the generalizations of calculating trend
lines and in using quetelet index ranges for each predicted cardiovascular risk factor.
Trial size - Each Monte Carlo simulation is performed for five iterations of 1,000 trials.
Therefore, each simulation is limited to a total of 5,000 trials. This number of trials is
assumed sufficient in achieving the Law of Large Numbers. Additionally, each iteration
utilizes a different algorithm for generating numbers and therefore achieves greater
randomness.
VI. Conclusion
This thesis examines the use of Monte Carlo computer simulation as a tool for
assisting organizations in identifying effective strategies for fighting childhood
overweight. The goal of this thesis is to help organizations understand the benefits and
limitations of computer simulation modeling in predicting cardiovascular risk factors
among overweight children and adolescents.
The Monte Carlo computer models presented in Chapter IV (Figures IV-3 and IV4) assisted in explaining the relationships that exist between BMI and cardiovascular risk
factors in children and adolescents. Additionally, a sensitivity analysis was utilized to
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determine the risk factors most sensitive to weight status. Utilizing this information
public health professionals can better make decisions regarding what interventions should
receive attention, funding and resources.
A multiple risk factor analysis also was performed to illustrate how changes in
BMI impact changes in co-existing risk factors. Utilizing this methodology public health
professionals can quantify the degree by which changes in BMI impact probabilities for
co-existing risk factors.
A “what-if” scenario analysis compared how percentages of children and
adolescents with cardiovascular risk factors may change if BMI levels were to return to
2000 CDC standards (see Appendix A). Public health professionals may find this
analysis helpful when leveraging data produced through pilot programs. Through pilot
programs, health professionals may create their own probabilities and customized
algorithms for predicting future events. The application of Monte Carlo simulation is not
limited to any specific public health problem and/or intervention. Any event that evolves
dynamically over time (e.g., disease, injury or behavior) can be assessed as long as data is
available for defining a probability distribution. This creates an almost unlimited number
of opportunities for applying simulation to public health (e.g. predicting the occurrence of
global pandemics, response times to terrorist attacks or spread of HIV/AIDS).
According to Haddix, Teutsch and Corso (2003) Monte Carlo modeling can also
be used for “extrapolating costs and health effects beyond the time horizon of a single
clinical study. These models can also provide quantitative insight into the relative
importance of different components of the screening process and investigate how costeffectiveness ratios will change if values of key parameters are changed (Haddix,
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Teutsch, Corso, 2003, p124). It may be beneficial for future researchers to build financial
and resource variables directly into the model for enhanced decision-making ability.
Additionally, future research may assist in expanding the proposed model to
include other variables such as caloric burn and/or caloric intake. Likewise, the model
may be subdivided to achieve greater granularity by age, sex, race and ethnicity. There
really is no limit in refining the model. The more detailed the model the more accurate
the results.
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VIII. Appendix A – CDC growth charts: BMI-for-age percentiles

National Center for Health Statistics in collaboration with the National Center for Chronic Disease
Prevention and Health Promotion, 2000
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National Center for Health Statistics in collaboration with the National Center for Chronic Disease
Prevention and Health Promotion, 2000
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IX. Appendix B – Prevalence of overweight in children and adolescents 1999-2004

Source: Ogden, C. L., Carroll, M.D., Curtin, L.R., McDowell M.A., Tabak, C.J., Flegal K.M. (2006).
Prevalence of Overweight and Obesity in the United States, 1999-2004. Journal American Medical
Association (JAMA), 295, 1549-1555
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X. Appendix C – Overweight children & adolescents 1963–65 through 1999–2002

Source: National Center for Health Statistics. Health, United States, 2004 with Chartbook on Trends in
the Health of Americans. Hyattsville, Maryland: 2004.
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XI. Appendix D – Computer Simulation Theoretical Example
To explore the concept of simulation consider a theoretical example where an
individual suffers from frequent headaches. Suppose headaches are classified into
categories of weak, medium, bad or pounding. Table D.1 lists all possible headache
outcomes. The corresponding probabilities indicate the likelihood of the individual’s
status escalating to a given severity level within a 24 hour period.
Table D.1 Simulation example - sample probabilities

Severity Level
1
2
3
4
5

Outcomes
no headache
weak headache
medium headache
bad headache
pounding headache

Probability
0.70
0.12
0.09
0.06
0.03

The above probabilities are helpful. However, headache outcome
probabilities are more useful when defined using conditional probabilities. For
example, assume that headache severity is related to the quality of lunch consumed
that day (e.g., an individual has a higher probability of getting a headache given the
individual ate a low quality lunch).
The first step is to develop a distribution of the conditional variable. The
following table provides definitions for quality of lunch consumed in a 24-hour
period.
Table D.2 Simulation example - initial lunch quality levels

Quality Level
1
2
3
4
5

Category
skipped lunch
poor lunch
fair lunch
good lunch
great lunch

Probability
0.05
0.20
0.35
0.30
0.10
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Utilizing Bayes Law, five new probability distributions are identified within the next five
tables.
Table D.3 Probabilities by headache severity given individual skipped lunch

Severity Level
1
2
3
4
5

Outcomes
no headache
weak headache
medium headache
bad headache
pounding headache

Probability
0.62
0.14
0.11
0.08
0.05

Table D.4 Probabilities by headache severity given individual ate a poor quality lunch

Severity Level
1
2
3
4
5

Outcomes
no headache
weak headache
medium headache
bad headache
pounding headache

Probability
0.66
0.13
0.10
0.07
0.04

Table D.5 Probabilities by headache severity given individual ate a fair quality lunch

Severity Level
1
2
3
4
5

Outcomes
no headache
weak headache
medium headache
bad headache
pounding headache

Probability
0.70
0.12
0.09
0.06
0.03

Table D.6 Probabilities by headache severity given individual ate a good quality lunch

Severity Level
1
2
3
4
5

Outcomes
no headache
weak headache
medium headache
bad headache
pounding headache

Probability
0.74
0.11
0.08
0.05
0.02

Table D.7 Probabilities by headache severity given individual ate a lunch of great quality

Severity Level
1
2
3
4
5

Outcomes
no headache
weak headache
medium headache
bad headache
pounding headache

Probability
0.78
0.10
0.07
0.04
0.01
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Utilizing the above probabilities a model is constructed as shown below.
Figure D.1 Simulation model of headache severity

Utilizing a random number generator, a simulation of 1,000 Monte Carlo trials
is performed. The resulting probabilities by headache severity are defined below.
Figure D.2 Relative frequency diagram of headache severity
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Now that the current situation is modeled, assume an intervention is
implemented that improves the probability distribution for quality of lunch consumed.
The question is now: What is the expected outcome by headache severity given recent
changes in quality of lunch consumed? For this case, a revised probability
distribution for quality of lunch consumed is utilized as follows:
Table D.8 Simulation example - revised lunch quality levels

Quality Level
1
2
3
4
5

Category
skipped lunch
poor lunch
fair lunch
good lunch
great lunch

Probability
0.00
0.05
0.20
0.35
0.40

The only modification required in the existing model is a change for
probabilities of lunch quality. The simulation is run again utilizing 1,000 Monte
Carlo trails. The results are displayed in the following relative frequency diagram.
Figure D.3 Relative frequency diagram for headache severity after intervention
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The new distribution of headache severity has significantly shifted to the left,
indicating a drop in headache severity level. This may provide useful when
comparing the outcomes of various interventions.
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XII. Appendix E – Relationships between quetelet index and risk factor probability
Figure XII-1 Relationship of quetelet index in children ages 5-10 to probability of total cholesterol >
200 mg/dL

Figure XII-2 Relationship of quetelet index in children ages 11-17 to probability of total cholesterol >
200 mg/dL
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Figure XII-3 Relationship of quetelet index in children ages 5-10 to probability of triglycerides > 130
mg/dL

Figure XII-4 Relationship of quetelet index in children ages 11-17 to probability of triglycerides >
130 mg/dL
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Figure XII-5 Relationship of quetelet index in children ages 5-10 to probability of low-density
lipoprotein cholesterol > 130 mg/dL

Figure XII-6 Relationship of quetelet index in children ages 11-17 to probability of low-density
lipoprotein cholesterol > 130 mg/dL
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Figure XII-7 Relationship of quetelet index in children ages 5-10 to probability of high-density
lipoprotein cholesterol < 35 mg/dL

Figure XII-8 Relationship of quetelet index in children ages 11-17 to probability of high-density
lipoprotein cholesterol < 35 mg/dL
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Figure XII-9 Relationship of quetelet index in children ages 5-10 to probability of fasting insulin >
95th percentile

Figure XII-10 Relationship of quetelet index in children ages 11-17 to probability of fasting insulin >
95th percentile

Page 73

Figure XII-11 Relationship of quetelet index in children Ages 5-10 to probability of systolic blood
pressure > 95th percentile

Figure XII-12 Relationship of quetelet index in children ages 11-17 to probability of systolic blood
pressure > 95th percentile
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Figure XII-13 Relationship of quetelet index in children ages 5-10 to probability of diastolic blood
pressure > 95th percentile

Figure XII-14 Relationship of quetelet index in children ages 11-17 to probability of diastolic blood
pressure > 95th percentile
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XIII. Appendix F – Model comparison by cardiovascular risk factor
Figure XIII-1 Simulation comparison- Children ages 5 to 10 w/ total cholesterol > 200 mg/dL

Children ages 5 to 10 w/ total cholesterol > 200
mg/dL
645
700
600

11.8%

615
8.6%

17.7%

14.3%

70.5%

77.1%

500
400
300
200
100
0
Observed Distribution
healthy weight

2000 Distribution

"at risk but not overweight"

"overweight"

Figure XIII-2 Simulation comparison- Children ages 5 to 10 w/ triglycerides > 130 mg/dL
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Figure XIII-3 Simulation comparison- Children ages 5 to 10 w/ low-density lipoprotein cholesterol >
130 mg/dL

Children ages 5 to 10 w/ low-density lipoprotein
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Figure XIII-4 Simulation comparison- Children ages 5 to 10 w/ high-density lipoprotein cholesterol <
35 mg/dL
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Figure XIII-5 Simulation comparison- Children ages 5 to 10 w/ fasting insulin > 95th percentile
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Figure XIII-6 Simulation comparison- Children ages 5 to 10 w/ systolic blood pressure > 95th
percentile
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Figure XIII-7 Simulation comparison- Children ages 5 to 10 w/ diastolic blood pressure > 95th
percentile
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Figure XIII-8 Simulation comparison- Children ages 5 to 10 w/ 0 out of 7 risk factors
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Figure XIII-9 Simulation comparison- Children ages 5 to 10 w/ 1 out of 7 risk factors

Children ages 5 to 10 w/ 1 out of 7 risk factors
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Figure XIII-10 Simulation comparison- Children ages 5 to 10 w/ 2 out of 7 risk factors

Children ages 5 to 10 w/ 2 out of 7 risk factors
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Figure XIII-11 Simulation comparison- Children ages 5 to 10 w/ 3 out of 7 risk factors

Children ages 5 to 10 w/ 3 out of 7 risk factors
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Figure XIII-12 Simulation comparison- Children ages 5 to 10 w/ 4 out of 7 risk factors

Children ages 5 to 10 w/ 4 out of 7 risk factors
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Figure XIII-13 Simulation comparison- Children ages 5 to 10 w/ (5 or more) out of 7 risk factors
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Children ages 5 to 10 w/ (5 or more) out of 7 risk
factors
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Figure XIII-14 Simulation comparison- Children ages 11 to 17 w/ total cholesterol > 200 mg/dL

Children ages 11 to 17 w/ total cholesterol > 200
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Figure XIII-15 Simulation comparison- Children ages 11 to 17 w/ triglycerides > 130 mg/dL

Children ages 11 to 17 w/ triglycerides > 130 mg/dL
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Figure XIII-16 Simulation comparison- Children ages 11 to 17 w/ low-density lipoprotein cholesterol
> 130 mg/dL
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Figure XIII-17 Simulation comparison- Children ages 11 to 17 w/ high-density lipoprotein cholesterol
< 35 mg/dL

Children ages 11 to 17 w/ high-density lipoprotein
cholesterol < 35 mg/dL
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Figure XIII-18 Simulation comparison- Children ages 11 to 17 w/ fasting insulin > 95th percentile

Children ages 11 to 17 w/ fasting insulin > 95th
percentile
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Figure XIII-19 Simulation comparison- Children ages 11 to 17 w/ systolic blood pressure > 95th
percentile

Children ages 11 to 17 w/ systolic blood pressure >
95th percentile
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Figure XIII-20 Simulation comparison- Children ages 11 to 17 w/ diastolic blood pressure > 95th
percentile

Children ages 11 to 17 w/ diastolic blood pressure >
95th percentile
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Figure XIII-21 Simulation comparison- Children ages 11 to 17 w/ 0 out of 7 risk factors

Children ages 11 to 17 w/ 0 out of 7 risk factors
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Figure XIIII-22 Simulation comparison- Children ages 11 to 17 w/ 1 out of 7 risk factors

Children ages 11 to 17 w/ 1 out of 7 risk factors
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Figure XIIII-23 Simulation comparison- Children ages 11 to 17 w/ 2 out of 7 risk factors

Children ages 11 to 17 w/ 2 out of 7 risk factors
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Figure XIIII-24 Simulation comparison- Children ages 11 to 17 w/ 3 out of 7 risk factors

Children ages 11 to 17 w/ 3 out of 7 risk factors
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Figure XIIII-25 Simulation comparison- Children ages 11 to 17 w/ 4 out of 7 risk factors

Children ages 11 to 17 w/ 4 out of 7 risk factors

10

10
8

9
8
7

60%
50%

6
5
4
3
2
1
0

25%

30%

25%
10%
Observed Distribution
healthy weight

2000 Distribution

"at risk but not overweight"

"overweight"

Figure XIIII-26 Simulation comparison- Children ages 11 to 17 w/ (5 or more) out of 7 risk factors
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